PTEN and neoplasm: In the context of Pten null PCa where DNL contributes to the increase of TAG and PL pools, targeting of the SREBP-mediated lipogenic program using fatostatin also impedes distant lymph node metastasis, as well as primary tumor growth by decreasing the frequency of mitotic cancer cells and activating apoptosis [38].